Who Are Candidates for Adjuvant Therapy in Prostate Cancer? | Ask a Prostate Expert, Mark Scholz, MD
2.8 هزار بار بازدید -
4 سال پیش
-
Who should consider adjuvant hormone
Who should consider adjuvant hormone therapy in addition to their local therapy? Should second-generation anti-androgens (e.g. Zytiga, Xtandi, Erleada, Nubeqa) be used as well? Medical oncologist, Mark Scholz, MD answers these questions and more.
0:06 How does adjuvant hormone therapy affect outcomes compared to patients who do not use it?
0:48 Who is a candidate for adjuvant hormone therapy?
1:26 Does adjuvant therapy ever include second-generation anti-androgens like Xtandi, Zytiga, Erleada, and Nubeqa?
2:06 Is there an age when adjuvant therapy would no longer be indicated?
2:50 Is adjuvant hormone therapy indicated for men undergoing radical prostatectomy?
3:33 Should those undergoing short-course hormone therapy be taking osteoporosis drugs?
4:26 How commonly do patients stop adjuvant hormone therapy because the side effects were considered intolerable, and is that okay?
Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org
To learn more about prostate cancer visit http://www.pcri.org
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.
#ProstateCancer #Prostate #MarkScholzMD
0:06 How does adjuvant hormone therapy affect outcomes compared to patients who do not use it?
0:48 Who is a candidate for adjuvant hormone therapy?
1:26 Does adjuvant therapy ever include second-generation anti-androgens like Xtandi, Zytiga, Erleada, and Nubeqa?
2:06 Is there an age when adjuvant therapy would no longer be indicated?
2:50 Is adjuvant hormone therapy indicated for men undergoing radical prostatectomy?
3:33 Should those undergoing short-course hormone therapy be taking osteoporosis drugs?
4:26 How commonly do patients stop adjuvant hormone therapy because the side effects were considered intolerable, and is that okay?
Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org
To learn more about prostate cancer visit http://www.pcri.org
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.
#ProstateCancer #Prostate #MarkScholzMD
4 سال پیش
در تاریخ 1399/08/26 منتشر شده
است.
2,822
بـار بازدید شده